EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Role of Calcium Modulation in the Pathophysiology and Treatment of Alzheimer’s Disease

Daniela Baracaldo-Santamaría iD, Sara Sofia Avendaño-Lopez, Daniel Felipe Ariza-Salamanca iD, Mateo Rodriguez-Giraldo, Carlos A Calderon-Ospina iD, Rodrigo E González-Reyes iD, Mauricio O Nava-Mesa iD

International Journal of Molecular Sciences · 22.05.2023 · 24 (10) · 9067

DOI: 10.3390/ijms24109067 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.05.2023. Verfasst von Daniela Baracaldo-Santamaría und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Unit, Department of Biomedical Sciences, School of Medicine and Health Sciences, Universidad del Rosario, Bogotá 111221, Colombia. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 359 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad del Rosario (Bogotá, Colombia).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a chronic neurodegenerative disease and the most frequent cause of progressive dementia in senior adults. It is characterized by memory loss and cognitive impairment secondary to cholinergic dysfunction and N-methyl-D-aspartate (NMDA)-mediated neurotoxicity. Intracellular neurofibrillary tangles, extracellular plaques composed of amyloid-β (Aβ), and selective neurodegeneration are the anatomopathological hallmarks of this disease. The dysregulation of calcium may be present in all the stages of AD, and it is associated with other pathophysiological mechanisms, such as mitochondrial failure, oxidative stress, and chronic neuroinflammation. Although the cytosolic calcium alterations in AD are not completely elucidated, some calcium-permeable channels, transporters, pumps, and receptors have been shown to be involved at the neuronal and glial levels. In particular, the relationship between glutamatergic NMDA receptor (NMDAR) activity and amyloidosis has been widely documented. Other pathophysiological mechanisms involved in calcium dyshomeostasis include the activation of L-type voltage-dependent calcium channels, transient receptor potential channels, and ryanodine receptors, among many others. This review aims to update the calcium-dysregulation mechanisms in AD and discuss targets and molecules with therapeutic potential based on their modulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeurodegenerative DiseasesHumansCalciumAmyloid beta-PeptidesCalcium, DietaryCalcium Channels, L-Type

Stichwörter der Autor:innen

Alzheimer’s diseasecalciumcalcium channelscalcium homeostasisdementiatherapy

Substanzen

CalciumAmyloid beta-PeptidesCalcium, DietaryCalcium Channels, L-Type

Autor:innen und Institutionen

  • Pharmacology Unit, Department of Biomedical Sciences, School of Medicine and Health Sciences, Universidad del Rosario, Bogotá 111221, Colombia.
  • Medical and Health Sciences Education Research Group, School of Medicine and Health Sciences, Universidad del Rosario, Bogotá 111221, Colombia.
  • Grupo de Investigación en Neurociencias (NeURos), Centro de Neurociencias Neurovitae-UR, Instituto de Medicina Traslacional (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá 111221, Colo…
  • Grupo de Investigación en Ciencias Biomédicas Aplicadas (UR Biomed), School of Medicine and Health Sciences, Universidad del Rosario, Bogotá 111221, Colombia.

ORCID-Profile: Daniela Baracaldo-Santamaría, Daniel Felipe Ariza-Salamanca, Carlos A Calderon-Ospina, Rodrigo E González-Reyes, Mauricio O Nava-Mesa

Förderung

  • Universidad del Rosario (Bogotá, Colombia)

Zitieren

APA

Baracaldo-Santamaría, D., Avendaño-Lopez, S. S., Ariza-Salamanca, D. F., Rodriguez-Giraldo, M., Calderon-Ospina, C. A., González-Reyes, R. E., & Nava-Mesa, M. O. (2023). Role of Calcium Modulation in the Pathophysiology and Treatment of Alzheimer’s Disease. International Journal of Molecular Sciences, 24(10), 9067. https://doi.org/10.3390/ijms24109067

Vancouver

Baracaldo-Santamaría D, Avendaño-Lopez SS, Ariza-Salamanca DF, Rodriguez-Giraldo M, Calderon-Ospina CA, González-Reyes RE, et al. Role of Calcium Modulation in the Pathophysiology and Treatment of Alzheimer’s Disease. International Journal of Molecular Sciences. 2023;24(10):9067. doi:10.3390/ijms24109067

BibTeX
@article{BaracaldoSantamara2023,
  author = {Baracaldo-Santamaría, Daniela and Avendaño-Lopez, Sara Sofia and Ariza-Salamanca, Daniel Felipe and Rodriguez-Giraldo, Mateo and Calderon-Ospina, Carlos A and González-Reyes, Rodrigo E and Nava-Mesa, Mauricio O},
  title = {Role of Calcium Modulation in the Pathophysiology and Treatment of Alzheimer’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {10},
  pages = {9067},
  doi = {10.3390/ijms24109067}
}
Kostenlos starten →